# Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG

> **NCT03219632** · — · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 72 (actual)

## Conditions studied

- Left Ventricular Hypertrophy
- Hypertension

## Interventions

- **DRUG:** Fimasartan

## Key facts

- **NCT ID:** NCT03219632
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-05
- **Primary completion:** 2017-04-30
- **Final completion:** 2017-05-30
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2017-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03219632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03219632, "Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03219632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*